Recherche
-
POMC neuronal heterogeneity in energy balance and beyond: an integrated view
(Nature Metabolism. vol. 3, n° 3, pp. 299-308, 2021-03)Article de revueLibre accès -
Epidemics and outbreaks of peripheral nervous system disorders: II. Toxic and nutritional causes
(Journal of Neurology. vol. 268, n° 3, pp. 892-902, 2021-03)Article de revue -
(Re)contextualizing the Trauma to Prevent or Treat PTSD-Related Hypermnesia
(Chronic Stress. vol. 5, 2021-05-26)Article de revueLibre accès -
Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
(Neurobiology of Disease. vol. 160, pp. 105533, 2021-12-01)Article de revueLibre accès -
CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity
(Diabetes. vol. 70, n° 2, pp. 415-422, 2021-02)Article de revue -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
Olfaction and anosmia: From ancient times to COVID-19
(Journal of the Neurological Sciences. vol. 425, 2021-06-15)Article de revueLibre accès -
Cannabis and exercise: Effects of Δ9-tetrahydrocannabinol on preference and motivation for wheel-running in mice
(Progress in Neuro-Psychopharmacology & Biological Psychiatry. vol. 105, 2021-03-08)Article de revueLibre accès -
Identification of BiP as a CB1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain
(Journal of Neuroscience. vol. 41, n° 38, pp. 7924-7941, 2021-09-22)Article de revueLibre accès -
New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type-1 cannabinoid receptor (CB1R) activity and function
(Journal of Neuroendocrinology. vol. 34, n° 2, 2022-02)Article de revueLibre accès